Article metrics
PDF
Other content recommended for you
- Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study
- Glucocorticoid-induced osteoporosis
- Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density
- Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids
- What is osteoporosis?
- Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study
- The pathogenesis, diagnosis, investigation and management of osteoporosis
- From bone biology to clinical outcome: state of the art and future perspectives
- Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study
- Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study